Prostate Cancer News and Research

RSS
Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.

Further Reading

Researchers receive $3.2 million NIH grant to pursue a deeper understanding of Down syndrome

Researchers receive $3.2 million NIH grant to pursue a deeper understanding of Down syndrome

Study to examine whether cancer and co-occurring Alzheimer's alter pain perception

Study to examine whether cancer and co-occurring Alzheimer's alter pain perception

High consumption of dairy products linked to increased prostate cancer risk

High consumption of dairy products linked to increased prostate cancer risk

New guidance from oncology experts recommends tailored exercise prescriptions

New guidance from oncology experts recommends tailored exercise prescriptions

New recommendations outline specific 'exercise prescriptions' for cancer survivors

New recommendations outline specific 'exercise prescriptions' for cancer survivors

Researchers outline new exercise recommendations for people living with and beyond cancer

Researchers outline new exercise recommendations for people living with and beyond cancer

Low-risk thyroid cancer and stringent follow-up: who decides?

Low-risk thyroid cancer and stringent follow-up: who decides?

New guidance recommends systematic use of 'exercise prescription' for cancer patients

New guidance recommends systematic use of 'exercise prescription' for cancer patients

Combination of two drugs disrupts cancer cells' ability to survive DNA damage, study finds

Combination of two drugs disrupts cancer cells' ability to survive DNA damage, study finds

New microfluidic test can detect Lyme disease within 15 minutes

New microfluidic test can detect Lyme disease within 15 minutes

More sensitive electrophysiology tools needed to study cancer cell populations

More sensitive electrophysiology tools needed to study cancer cell populations

Lab-grown, testosterone-producing cells could help treat hypogonadism

Lab-grown, testosterone-producing cells could help treat hypogonadism

Statin use linked with lower risk of developing prostate cancer

Statin use linked with lower risk of developing prostate cancer

Study shows association between mushroom consumption and lower risk of prostate cancer

Study shows association between mushroom consumption and lower risk of prostate cancer

Osaka University Hospital begins clinical research for prostate cancer diagnosis using PET imaging

Osaka University Hospital begins clinical research for prostate cancer diagnosis using PET imaging

Research provides new insights into tumorigenesis of meningioma

Research provides new insights into tumorigenesis of meningioma

New anticancer molecule shows therapeutic activity in preclinical models of various cancer types

New anticancer molecule shows therapeutic activity in preclinical models of various cancer types

Unique biomarker in urine may offer non-invasive means of detecting prostate cancer

Unique biomarker in urine may offer non-invasive means of detecting prostate cancer

Targeted therapy slows disease progression and improves survival for prostate cancer

Targeted therapy slows disease progression and improves survival for prostate cancer

Modern chemo more effective than second targeted hormone therapy against resistant prostate cancer

Modern chemo more effective than second targeted hormone therapy against resistant prostate cancer